Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In Reply In our Viewpoint, we highlighted the following issues: (1) bringing attention to the risks associated with intracorporeal morcellation, (2) using alternatives to unprotected or unenclosed intracorporeal morcellation, (3) developing safer techniques and instruments, and (4) encouraging improvements in surgical procedure and device monitoring.
We reiterate our concern that appropriate and safe use of medical technology is paramount, yet we must disagree with Dr Melamed’s suggestion that the current understanding and instrumentation will suffice. Much work remains to be done to address concerns regarding intracorporeal morcellation, including quantifying the risks of both benign and occult malignant tissue dissemination, as well as risks of iatrogenic tissue injury. Increased scrutiny on the topic stresses the importance of discussing these issues, which have been a concern for the past several years.1,2
Kho KA, Nezhat CH. Electric Uterine Morcellation—Reply. JAMA. 2014;312(1):96-97. doi:10.1001/jama.2014.6172